In addition, in mouse models, PHF23 and CHD3 have been identified as potential TSGs, and the deletion of these genes may promote tumor development through p53-dependent or p53-independent mechanisms (Yu et al., 2017). The gene discussed is TP53; the disease is neoplasm.